Related Experiment Video
Updated: Jan 20, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Increased risk of pulmonary hypertension following premature birth
Estelle Naumburg1,2, Lars Söderström3
1Department of Clinical Science, Pediatrics, Umeå University, Umeå, Sweden. Estelle.naumburg@umu.se.
Insights
Premature birth significantly increases the risk of developing pulmonary hypertension (PAH). This risk has notably risen in recent decades, suggesting unknown factors may contribute to PAH in preterm infants.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Public Health Epidemiology
Background:
- Pulmonary hypertension (PAH) is linked to premature birth, independent of known risk factors.
- Modern neonatal care advancements have increased survival rates for preterm infants.
Purpose of the Study:
- To assess the risk of PAH associated with premature birth and other factors.
- To examine trends in PAH risk over decades of changing neonatal care.
Main Methods:
- Population-based registry study matching PAH cases with controls.
- Conditional multiple logistic regression to adjust for confounding factors.
- Analysis of birth data from 1973-2010, grouped into five-year intervals.
Main Results:
- Preterm birth was over three times more common in PAH cases (21%) vs. controls (6%).
- Adjusted risk of PAH associated with premature birth was OR=4.48.
- Risk of PAH following premature birth increased significantly for those born in the 2000s (OR=17.08).
Conclusions:
- Preterm birth is a significant contributor to PAH.
- PAH risk following premature birth has increased over recent decades.
- Unknown factors may influence the development of PAH in preterm infants.
Background:
Pulmonary hypertension (PAH) among children and adults has been linked to premature birth, even after adjustments for known risk factors such as congenital heart disease and chronic lung disease. The aim of this population-based registry study was to assess the risk of PAH following exposure to premature birth and other factors in the decades when modern neonatal care was introduced and survival rates increased.
Methods:
Data on pulmonary hypertension and perinatal factors were retrieved from population-based governmental and national quality registers. Cases were adults and children over five years of age with pulmonary hypertension born from 1973 to 2010 and individually matched to six controls by birth year and delivery hospital. Conditional multiple logistic regression was performed to assess the risk of pulmonary hypertension following premature birth and to adjust for known confounding factors for the total study population and for time of birth, grouped into five-year intervals.
Results:
In total, 128 cases and 768 controls were included in the study group. Preterm birth was over three times more common among cases (21%) than among controls (6%). The overall adjusted risk of pulmonary hypertension was associated with premature birth, OR = 4.48 (95% CI; 2.10-9.53). Maternal hypertension, several neonatal risk factors and female gender were independently associated with PAH when potential confounders were taken into account. For each five-year period, the risk of PAH following premature birth increased several times for children born in the 2000s and later, OR = 17.08 (95% CI 5.60-52.14).
Conclusions:
Preterm birth, along with other factors, significantly contributes to PAH. PAH following premature birth has increased over the last few decades. Our study indicates that new, yet unknown factors may play a role in the risk of preterm-born infants developing PAH later in life.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Birth Control Methods
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

